Submission Details
| 510(k) Number | K122722 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 05, 2012 |
| Decision Date | November 29, 2012 |
| Days to Decision | 85 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K122722 is an FDA 510(k) clearance for the COBAS C TINA-QUANT LIPOPROTEIN (A) GEN 2 ASSAY MODEL 05852625190; PRECISET LP (A) GEN 2 CALIFRATOR SET MODEL 05852641160, a Lipoprotein, Low-density, Antigen, Antiserum, Control (Class II — Special Controls, product code DFC), submitted by Roche Diagnostics (Indianapolis, US). The FDA issued a Cleared decision on November 29, 2012, 85 days after receiving the submission on September 5, 2012. This device falls under the Chemistry review panel. Regulated under 21 CFR 866.5600.
| 510(k) Number | K122722 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 05, 2012 |
| Decision Date | November 29, 2012 |
| Days to Decision | 85 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | DFC — Lipoprotein, Low-density, Antigen, Antiserum, Control |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.5600 |